Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 5818 El Camino Real CARLSBAD CA 92008 |
Tel: | 1-760-4946750 |
Website: | https://atecspine.com |
IR: | See website |
Key People | ||
Patrick S. Miles Chairman of the Board, President, Chief Executive Officer | Tyson Eliot Marshall General Counsel, Corporate Secretary | J. Todd Koning Chief Financial Officer, Executive Vice President |
Scott Lish Chief Operating Officer | David M. Sponsel Executive Vice President - Sales | Eric Dasso Executive Vice President - Adjunctive Technologies |
Kelli Mari Howell Executive Vice President - Clinical Strategies | Craig E. Hunsaker Executive Vice President - People and Culture | Ali Shorooghi Senior Vice President - Marketing | Joseph Walland Senior Vice President - Global Imaging Solutions |
Business Overview |
Alphatec Holdings, Inc., through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company. The Company is focused on the design, development, and advancement of technology for surgical treatment of spine disorders. It has a range of product portfolios designed to address the spine's various pathologies. Its AIX product platform comprises of its EOS imaging system and VEA alignment mobile application, its SafeOp Neural InformatiX System and Valence. The EOS imaging system is designed to provide calibrated full-body imaging that enables a three-dimensional (3D) model of patients' skeletal systems. It has developed a patient positioning systems that integrates with its other access systems, providing for a more rigid construct and enhanced reproducibility. It offers procedure-specific access systems, including its Sigma-ALIF Access System, which allows for custom anterior abdominal exposure. |
Financial Overview |
For the three months ended 31 March 2024, Alphatec Holdings Inc revenues increased 27% to $138.5M. Net loss increased 11% to $48.5M. Revenues reflect United States segment increase of 30% to $129.8M. Higher net loss reflects Design and development surgical treatement segment loss increase of 7% to $43.3M. Basic Earnings per Share excluding Extraordinary Items increased from -$0.40 to -$0.34. |